FACTORS ASSOCIATED WITH REAL-WORLD INPATIENT USE OF LONG-ACTING ATYPICAL ANTIPSYCHOTICS

被引：0
|
作者：
Fastenau, J. [1 ]
Campbell, R. S. [2 ]
Nathanson, B. H. [3 ]
Haidar, T. [2 ]
Yi, J. [2 ]
Wade, R. [2 ]
机构：
[1] Janssen Sci Affairs LLC, Titusville, NJ USA
[2] Cerner LifeSci Consulting, Beverly Hills, CA USA
[3] OptiStatim LLC, Longmeadow, MA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.463
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [21] Long-Acting Injectable Antipsychotics in the ElderlyGuidelines for Effective Use
    Prakash S. Masand
    Sanjay Gupta
    Drugs & Aging, 2003, 20 : 1099 - 1110
  • [22] Long-Acting Injectable Antipsychotics: Evidence of Effectiveness and Use
    Manchanda, Rahul
    Chue, Pierre
    Malla, Ashok
    Tibbo, Phil
    Roy, Marc-Andre
    Williams, Richard
    Iyer, Srividya
    Lutgens, Danyael
    Banks, Nicola
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2013, 58 (05): : 5S - 13S
  • [23] Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics
    Kisely, Steve
    Ligate, Loys
    Roy, Marc-Andre
    Lavery, Terri
    AUSTRALASIAN PSYCHIATRY, 2012, 20 (02) : 138 - 142
  • [24] Long-Acting Typical and Atypical Antipsychotics in Treatment of Schizophrenia: A Retrospective Comparison
    Virit, Osman
    Altindag, Abdurrahman
    Bulbul, Feridun
    Savas, Haluk Asuman
    Dalkilic, Alican
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (02): : 119 - 127
  • [25] Long-acting injectable atypical antipsychotics in adolescent population: an observational study
    Fortea, A.
    Espinosa, L.
    Ilzarbe, D.
    Solerdelcoll, M.
    De Castro, C.
    Oriolo, G.
    Sugranyes, G.
    Baeza, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S732 - S733
  • [26] LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Johnston, Karen
    Sliwa, Jennifer Kern
    Bossie, Cynthia A.
    Kim, Edward
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2019, 57 (11) : 5 - 5
  • [27] Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
    Barlati, Stefano
    Nibbio, Gabriele
    Bianchi, Francesco
    Gigli, Elena Butti Lemmi
    Calzavara-Pinton, Irene
    Cerati, Caterina
    Fiori, Jacopo
    Lisoni, Jacopo
    Deste, Giacomo
    Vita, Antonio
    PSYCHIATRY RESEARCH, 2022, 317
  • [28] Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study
    Antonio Garcia-Carmona, Juan
    Simal-Aguado, Jorge
    Pilar Campos-Navarro, Maria
    Valdivia-Munoz, Francisco
    Galindo-Tovar, Alejandro
    CLINICAL DRUG INVESTIGATION, 2020, 40 (05) : 459 - 468
  • [29] Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study
    Juan Antonio García-Carmona
    Jorge Simal-Aguado
    María Pilar Campos-Navarro
    Francisco Valdivia-Muñoz
    Alejandro Galindo-Tovar
    Clinical Drug Investigation, 2020, 40 : 459 - 468
  • [30] ADHERENCE ADVANTAGES OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS (LAIS) IN SCHIZOPHRENIA. IS THE CURRENTLY AVAILABLE REAL-WORLD EVIDENCE ADEQUATE OR CONCLUSIVE?
    Aslam, A.
    Nayak, R.
    VALUE IN HEALTH, 2022, 25 (07) : S593 - S594
12345